J.W.M. Neurology P.C.

Indianapolis, Indiana 46237

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Episodic Migraine Clinical Trial
To Evaluate the Safety and Tolerability of Atogepant 10mg, 30 mg and 60 mg Once a Day for the Prevention of Migraine in Participants With Episodic Migraine
Status: Enrolling, Phase III
Updated: 12/31/1969
J.W.M. Neurology P.C.
mi
from
Indianapolis, IN
Click here to add this to my saved trials